News Archives » shareholders
Cisco Shareholders Vote Down Oblate-Proposed Plan for Tax Transparency December 14th, 2022
Fr. Séamus Finn, OMI, Director, OMIUSA JPIC, OIP
“While payment of taxes does not rank high on anybody’s wish list, they are the contributions that individuals, organizations and institutions make at all levels so that governments can function and fulfill their responsibilities. Many corporations seek to hide from the public how much they pay in the different countries in which that they operate around the world. As shareholders and citizens, we believe that access to this information allows us to verify for ourselves if they are compliant in these matters and paying their fair share to support 
the common good, relieve the dire poverty and suffering of many and help to build a sustainable future for all. The OIP and the OMI USP have been leading proponents of this request with Cisco, Amazon and Microsoft, three of the largest companies resisting this proposal”. “This resolution with CISCO was supported by 27% of the shareholders last week, a vote total that is considered very acceptable for the first year that a resolution is presented, and allows us to present the resolution again in 2023”
Click here to see a report on Cisco’s action by Kevin Pinner for Law 360
Companies Urged to Keep COVID-19 Drugs Affordable Amid Pandemic May 8th, 2020
Now that the Food and Drug Administration has authorized remdesivir for emergency use in seriously ill COVID-19 patients, the experimental drug is another step closer to full approval. That’s when most drugs get price tags.
Gilead Sciences, which makes remdesivir, is donating its initial supply of 1.5 million doses, but the company has signaled it will need to start charging for the drug to make production sustainable. It’s unclear when that decision might be made. Read the full article at NPR.
Photo by Karolina Grabowska from Pexels
In early April investor members of the Interfaith Center on Corporate Responsibility (ICCR) sent letters to the CEOs of fourteen pharmaceutical companies calling for a collaborative approach in the development of health technologies, including diagnostics, treatments and a vaccine in the global fight against Covid-19.
The letter was sent to AbbVie (ABBV); Amgen (AMGN); Biogen (BIIB); Bristol-Myers Squibb (BMY); Gilead (GILD); GlaxoSmithKline (GSK); Eli Lilly (LLY); Johnson & Johnson (JNJ); Merck (MRK); Pfizer (PFE); Novartis (NVS); Roche (RHHBY); Sanofi (SNY) and; Vertex (VRTX). Read more.
As companies go virtual with Annual General Meetings, shareholders are finding ways to still participate in the process and convey concerns. ICCR has launched #AskTheCEO, a campaign to capture shareholders’ questions at these virtual meetings.
Visit ICCR’s website to read more about their #AskTheCEO campaign and watch shareholder videos.
